跳至主要内容
临床试验/NCT06013306
NCT06013306尚未招募不适用

Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study

Kang Stem Biotech Co., Ltd.0 个研究点目标入组 58 人开始时间: 2023年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
58
主要终点
Number of AESI

研究概览

简要总结

Long-Term Follow-up Study of Subjects with Knee Osteoarthritis who had administered FURESTEM-OA Kit Inj. in K0701 study

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Those who participated in the K0701 clinical trial and received PureStem-OA Kit Inj
  • Those who understand and voluntarily sign an informed consent form
  • exclusion criteria

排除标准

  • 未提供

结局指标

主要结局

Number of AESI

时间窗: 5 years follow-up after treatment

Number of SS

时间窗: 5 years follow-up after treatment

次要结局

  • Changes in 100-mm VAS(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Changes in International Knee Documentation Committee Scoring System (IKDC)(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Changes in Knee Injury and Osteoarthritis Outcome Score (KOOS)(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Evaluation of International K&L grade(X-ray)(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Changes in Western Ontario and McMaster Universities osteoarthritis index (WOMAC)(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Whole-Organ Magnetic Resonance Imaging Score (WORMS) score(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)
  • Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores(MRI)(1 year (52 weeks), 2 years (104 weeks), and 3 years (156 weeks) after treatment)

研究者

发起方
Kang Stem Biotech Co., Ltd.
申办方类型
Industry
责任方
Sponsor

相似试验